Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Clinical trial NCT06482112 · COMPLETED

Trial details

NCT number: NCT06482112
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Dysfunction-Associated Steatotic Liver Disease Non-alcoholic Fatty Liver Disease Nonalcoholic Fatty Liver Disease Liver Disease

Start date: 2024-07-29
Primary completion: 2025-06-27
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.